NASDAQ:AUPH

Aurinia Pharmaceuticals Stock News

etoro logo Buy AUPH
*Your capital is at risk
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bioxcel Therapeutics
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Entasis Therapeutics Holdings (ETTX) today and set a price target of $5.00. The company's
These three developmental-stage pharma stocks are attracting some of the smartest investors right now.
Yale scientists found that transcription factor HIF-1 helps T cells adapt to an oxygen-starved environment in the kidney and contributes to inflammation and tissue damage in lupus. Treatment with a HI
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
In a report released today, Alethia Young from Cantor Fitzgerald reiterated a Buy rating on Gilead Sciences (GILD), with a price target of $86.00. The
In a report released today, Alethia Young from Cantor Fitzgerald reiterated a Buy rating on Gilead Sciences ( GILD – Research Report ), with a price target of $86.00 . The company’s shares closed
Franklin Resources Inc. lessened its holdings in shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) (TSE:AUP) by 5.6% during the 4th quarter, according to its most recent disclosure with the SEC. The
venBio Closes $394 Million Life Sciences Venture Capital Fund, Bringing Total Assets Under Management to Nearly $1 Billion
Q4 2019 Aurinia Pharmaceuticals Inc Earnings Call
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aurinia Pharmaceuticals (AUPH), BerGenBio AS (BRRGF) and
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE